超越肺部:传播结核病的病例报告与多系统参与
Nuno Carvalho1,2, André Pereira2, Margarida Castro3
1School of Medicine, University of Minho, Braga, PRT.
传播性结核病 (TB) 是一种罕见的,具有挑战性的诊断,具有非特异性症状和多器官参与. 早期怀疑和快速诊断对于及时启动抗结核治疗和预防严重后果至关重要.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 类风湿病学 类风湿病学
背景情况:
- 结核病 (TB) 是一种由Mycobacterium tuberculosis引起的传染病.
- 传播性结核病是一种罕见的表现,涉及广泛的M.结核病传播,通常导致多器官参与和危及生命的疾病.
- 肺结核是常见的,但由于非特异性症状,传播形式存在诊断挑战.
研究的目的:
- 呈现一种传播性结核病病例,异常多器官参与,包括肺,和心脏表现.
- 突出与传播性结核病相关的诊断挑战以及早期怀疑的重要性.
- 强调在疑似扩散性结核病例中需要及时进行抗结核疗法.
主要方法:
- 一个55岁的男性病例报告,患有多关节痛,肌痛,疲劳,咳和减肥的症状.
- 诊断工作包括血液检查,尿液分析,胸腹盆腔CT扫描,和尿液中M.结核病DNA的PCR,脏活检,关节切片和心脏切片.
- 治疗涉及标准的四种药物抗结核疗法 (伊索尼亚,利芬,皮拉津胺,乙墨托尔).
主要成果:
- 这位患者出现了扩散性结核病,涉及肺部,脏 (介质血管扩散性结核炎) 和心脏 (溢出).
- 对M.结核病的初步诊断测试在一些样本中呈阴性,延迟了最终的诊断.
- 结核菌最终在唾液培养物中被发现,这导致了抗结核治疗的成功治疗,并在12个月后完全康复.
结论:
- 传播性结核病是一种罕见的疾病,由于其非特异性呈现和多器官参与的潜力,这给诊断带来了重大挑战.
- 临床医生必须保持对传播性结核病的高度怀疑指数,即使最初的微生物学结果是负面的.
- 及早和准确的诊断以及及时的抗结核疗法对于有利的结果和预防危及生命的并发症至关重要.
更多相关视频
09:02An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
相关概念视频
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
